Your browser doesn't support javascript.
loading
B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
Rahbar, Ramtin; Lin, Albert; Ghazarian, Magar; Yau, Helen-Loo; Paramathas, Sangeetha; Lang, Philipp A; Schildknecht, Anita; Elford, Alisha R; Garcia-Batres, Carlos; Martin, Bernard; Berman, Hal K; Leong, Wey L; McCready, David R; Reedijk, Michael; Done, Susan J; Miller, Naomi; Youngson, Bruce; Suh, Woong-Kyung; Mak, Tak W; Ohashi, Pamela S.
Affiliation
  • Rahbar R; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Lin A; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Ghazarian M; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Yau HL; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Paramathas S; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Lang PA; Department of Molecular Medicine II, Heinrich Heine University Dösseldorf, Dösseldorf, Germany.
  • Schildknecht A; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Elford AR; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Garcia-Batres C; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Martin B; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Berman HK; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network (UHN), Toronto, Ontario, Canada. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
  • Leong WL; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • McCready DR; Department of Surgical Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Reedijk M; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Done SJ; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network (UHN), Toronto, Ontario, Canada. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
  • Miller N; Laboratory Medicine Program, University Health Network (UHN), Toronto, Ontario, Canada. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Youngson B; Laboratory Medicine Program, University Health Network (UHN), Toronto, Ontario, Canada. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Suh WK; Immune Regulation Laboratory, Institut de Recherches Cliniques de Montreal (IRCM), Montreal, Quebec, Canada.
  • Mak TW; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Ohashi PS; Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Department of Immunology, University of Toronto, Toronto, Ontario, Canada. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. pohashi@uhnres.utoronto.ca.
Cancer Immunol Res ; 3(2): 184-95, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25527357
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Microenvironment / V-Set Domain-Containing T-Cell Activation Inhibitor 1 / Mammary Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Res Year: 2015 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Microenvironment / V-Set Domain-Containing T-Cell Activation Inhibitor 1 / Mammary Neoplasms, Experimental Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Res Year: 2015 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos